<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The EMBO Journal vol.8 6 pp. 1685 - 1693, 1989 <br />  <br />  <br /> Mutational analysis SEC4 suggests cyclical <br /> mechanism regulation vesicular traffic <br />  <br />  <br /> Nancy C.Walworth, Bruno Goud1, Alisa                                   form, protein resting inactive state. Exchange <br /> Kastan Kabcenell Peter J.Novick                                    <span id='am-1' about='obo:IMR_0001354' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:hasExactSynonym" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001354" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="GTP" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasAlternativeId" content="IMR:0200086" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasDbXref" content="KEGG:C00044" datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>GTP</span> <span id='am-9' about='obo:IMR_0001357' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C00035" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:id" content="IMR:0001357" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="GDP" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasAlternativeId" content="IMR:0200191" datatype="xsd:string"></span>GDP</span> results activation protein                                                                        GTP hydrolyzed. intrinsic hydrolysis activity Department Cell Biology, Yale University School Medicine,        exchange bound GDP new <br /> 333 Cedar Street, New Haven, CT 06510, USA <br />                                                                        molecule GTP processes affected &apos;Present address: Department Immunology, Institut Pasteur, Paris,   interaction proteins (Trahey McCormick, <br /> France                                                                 1987; Neer Clapham, 1988). <br /> Communicated P Carnilli                                             basic mechanisms GTP-binding proteins <br />                                                                        perform functions described. mammalian <br /> Mutant alleles SEC4, essential gene required                 G proteins, heterotrimeric protein complexes responsible final stage secretion yeast, generated             transduction extracellular signals, couple cell surface vitro mutagenesis. Deletion cysteine                  receptors intracellular enzymes produce regulatory <br /> residues C terminus protein results                 molecules cell. GTP bound state, soluble non-functional protein, indicating              activated G protein stimulates effector molecule residues required normal localization Sec4p                 increase intracellular level second messengers secretory vesicles plasma membrane. mutant                <span id='am-66' about='obo:IMR_0100024' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0001355 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-67' property="rdfs:label" content="Cyclic adenylic acid" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasExactSynonym" content="Cyclic AMP" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:id" content="IMR:0100024" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasDbXref" content="KEGG:C00575" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-73' property="rdfs:label" content="Cyclic AMP" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasAlternativeId" content="IMR:0200099" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasExactSynonym" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasExactSynonym" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-77' property="rdfs:label" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-78' property="rdfs:label" content="cAMP" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasExactSynonym" content="Cyclic adenylic acid" datatype="xsd:string"></span>cAMP</span>, Ca2+ inositol <span id='am-15' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-16' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-17' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="lipid" datatype="xsd:string"></span>lipid</span> products.  G <br /> allele SEC4 generated mimic activated, trans-                 protein initiates amplification signal, beginning <br /> forming allele H-ras, predicted, does bind GTP.              cascade events leads cellular response presence allele cells containing wild-type              (Gilman, 1987). <br /> SEC4 causes secretory defect accumulation                    alternative mechanism action GTP-binding <br /> secretory vesicles. results genetic studies indicate            protein ensure reaction occurs unidirectional allele behaves dominant loss function                fashion. bacterial protein synthesis factor EF-Tu <br /> mutant prevents wild-type protein                     mediates attachment subsequent release functioning properly. propose model Sec4p                macromolecular complex ribosome. process <br /> cycles active inactive state order                protein synthesis stopped vitro presence mediate fusion vesicles plasma membrane.              non-hydrolyzable GTP analog, GTP--y-S. EF-Tu, trapped <br /> Key words: GTP binding protein/secretion/Sec4p/ras                     GTP bound state, change conformation homolog/vesicular traffic                                              come ribosome allow round delivery <br />                                                                        occur.  single round <span id='am-41' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-42' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-46' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-48' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span>nucleotide</span> binding                                                                        hydrolysis, single event (delivery) takes place (Kaziro, <br /> Introduction                                                           1978). <br />                                                                           taken genetic approach determine SEC4 gene Saccharomyces cerevisiae encodes 24 kd              general mechanisms account GTP-binding protein plays essential role final         regulation secretion Sec4p. large stage secretion (Salminen Novick, 1987). Post-Golgi             information available structure GTP-binding <br /> secretory vesicles transported specific region         proteins function specific amino acids plasma membrane called bud subsequently fuse              structure, undertaken mutational analysis Sec4p membrane (Novick et al., 1980; Salminen Novick,               based characterized mutations proteins <br /> 1987). recessive temperature-sensitive mutation sec4              (Jurnak, 1985; LaCour et al., 1985; Vos et al., 1988). <br /> causes cells accumulate secretory vesicles restric-          Point mutations alter ability p21 H-ras bind <br /> tive temperature (Novick et al., 1980). localization            hydrolyze GTP known confer wild-type protein, Sec4p, cytoplasmic surface            protein capacity induce transformation secretory vesicles consistent participating          mammalian cells expressed (Barbacid, <br /> regulation transport recognition secretory               1987). <br /> vesicles plasma membrane (Goud et al., 1988).                     mutational studies yeast RAS proteins    GTP-binding proteins shown mediate diverse             regulate entry cells mitotic cell cycle GI, <br /> cellular processes. Members family proteins include         clear intact carboxy terminus required factors involved protein synthesis elongation factor        proper localization normal function proteins <br /> Tu (EF-Tu), G proteins involved signal transduction,            (Fujiyama Tamanoi, 1986; Deschenes Broach, product ras oncogene  Kaziro, 1978;                 1987). true oncogenic mammalian ras <br /> Barbacid, 1987; Gilman, 1987, reviews). proteins             proteins, transforming ability attached <br /> share ability assume different conformations depending          inner surface plasma membrane, usual GTP GDP bound                  location normal cellular version protein <br /> act regulatory switch. Generally, GDP bound                (Willumsen et al., 1984a,b). Yptlp, yeast ras-like protein <br />  <br />                                                                                                                                1685 <br />  N.C.Walworth et al. <br />  <br />  <br />  <br />  <br />                                                                           Fig. 2. Deletion C-terminal cysteines results soluble Sec4p. <br />                                                                           Lysates exponentially growing cells prepared osmotic lysis <br />                                                                           spheroplasts 0.8 M sorbitol followed 450 g centrifugation                                                                           remove unlysed cells (SI). SI spun 100 000 g yield <br />                                                                           membrane (P2) cytosolic fractions (S2).   NY678 sec4-8 <br />                                                                           strain (NY405) transformed pNB254 expresses                                                                           sec4-CCA gene. NY682 sec4-8 strain (NY405) transformed                                                                           pNBl70 expresses wild-type SEC4 gene. cases                                                                           plasmid encoded protein distinguished endogenous <br />                                                                           protein, Sec4-8p. (B) NY637 SEC&apos; strain (NY15) transformed <br />                                                                           pNB286 expresses Sec4-11e133,CCA gene. NY639                                                                           SEC+ strain (NY15) transformed pNBI41, integrating version <br />                                                                           pNBl39, expressing wild-type Sec4p. <br />  <br />                                                                           model membrane-associated Sec4p functions                                                                           cyclical fashion direct fusion post-Golgi secretory <br />                                                                           vesicles plasma membrane. <br /> Fig. 1. Documentation Sec4p expression levels various <br /> plasmid constructions. Sec4p plasmids         Results <br /> shown varies depending   genomic DNA 5&apos; initiator ATG included insert (ii) orientation      Deletion C-terminal cysteines prevents <br /> insert plasmid respect URA3 gene. right, <br /> total yeast lysates prepared glass bead lysis method           membrane attachment <br /> transferred SDS-polyacrylamide gel nitrocellulose filter     assess possible role membrane attachment incubated anti-Sec4p antibody alkaline phosphatase          C-terminal cysteine residues Sec4p, deleted <br /> conjugated secondary antibody. NY405, sec4-8 mutant strain,         site-specific mutagenesis (sec4-CCA, Materials <br /> transformed plasmid expressing wild-type SEC4 gene.         methods). Plasmid pNB254 (Figure 1), allows protein synthesized plasmid (Sec4p) distinguished endogenous protein (Sec4-8p) different      expression Sec4-CCAp higher wild-type <br /> mobilities. NY13 wild-type strain. plasmid pNB227 SEC4        levels, introduced temperature-sensitive sec4-8 <br /> gene oriented 3&apos; end near URA3 - 150 bp 5&apos; non-        strain. strain grow 37&#194;&#176;C unless rescued <br /> coding sequence present insert. Sec4p expressed low        functional copy SEC4. sec4-CCA gene level pNB227. Plasmid pNB170 size insert 227, orientation insert reversed, protein         pNB254 rescue strain, suggesting encodes <br /> expressed high levels. Plasmid pNB139 expresses Sec4p level       non-functional protein. plasmid wild-type cells approximately equivalent Sec4p     effect cell growth, indicating allele untransformed wild-type strain, NY13. pNB139               recessive wild-type allele. Overproduction orientation pNBl70 -400 bp non-coding region         Sec4-CCAp GAL] promoter does comple- <br /> SEC4 5&apos; end. Plasmids 227, 170 139 centromere- <br /> containing plasmids. Various plasmids used report include   ment temperature-sensitive growth defect sec4-8, integrating forms plasmids              GAL+ strain 37&#194;&#176;C (data shown). <br /> centromere integrating plasmids expressing mutant forms SEC4.         confirm hypothesis Sec4-CCAp                                                                           functional protein, performed gene replacement implicated function earlier stage               experiment makes sec4-CCA sole copy SEC4 secretory pathway (Segev et al., 1988), terminates                 cell. integrating plasmid containing sec4-CCA cysteine residues essential proper                      introduced diploid strain chromosome <br /> functioning protein (Molenaar et al., 1988). Sec4p                complete wild-type copy gene terminates cysteines.                                       chromosome complete copy sec4-CCA <br />    specific <span id='am-49' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-50' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-52' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span> changes GTP-                   gene marked URA3 selectable marker. binding domains Sec4p, C terminus,                sporulation dissection resulting tetrads viable attempt alter biochemical activities study              spores Ura+ (data shown). effects changes function protein vivo.           result demonstrates sec4-CCA gene sufficient <br /> Using mutants, hoped distinguish                  support growth copy sec4 cell. mechanisms described. Like signal transducing G                      determine intracellular location Sec4-CCAp, <br /> proteins, Sec4p serve amplify signal required              isogenic strains constructed plasmid pNB254 <br /> secretion regulating level <span id='am-61' about='obo:IMR_0100022' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-62' property="rdfs:label" content="second messenger" datatype="xsd:string"></span><span id='am-63' property="obo:IAO_0000115" content="Small molecule that is formed in or released into the cytosol in response to an extracellular signal and helps to relay the signal to the interior of the cell. Examples include cAMP, IP3, and Ca++." datatype="xsd:string"></span><span id='am-64' property="oboInOwl:id" content="IMR:0100022" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>second messenger</span>                   (sec4-CCt, NY678) pNB170 (SEC4, NY682) cell. Alternatively, like EF-Tu, Sec4p                   introduced NY405. Lysates prepared osmotic <br /> function direct macromolecular structure specific               lysis spheroplasts, membrane soluble fractions <br /> location cell. phenotypes mutants described                 generated centrifugation 100 000 g  Materials paper suggest mechanism action Sec4p               methods). Western blot, proteins expressed closely resemble EF-Tu. propose                     plasmids distinguished endogenous <br />  <br /> 1686 <br />                                                                                                                                   Regulation vesicular traffic Sec4p <br />  <br />  <br />                                                                                                           expressed mammalian cells (Barbacid, 1987). <br />  SEC4      NHz-GDSGVGKS--OTAGOER--LVGNKSDM-ESSAKND-o                                                         changed asparagine position 133 Sec4p <br />  YPTS       -GNSGVGKS--DTAGOERLVGNKCDL-ESALD. <br />                                                                                                           isoleucine. analogous mutation position 116                  *                      *          *                                                      H-ras results oncogenic transformation despite inability <br />  H-m.       -GAGGVGKS--DTAGOEE-LVGNKCDL                            .ETSAKTR                               protein detectably bind GTP (Walter et al., 1986). <br />  EF-Tu        -GHVDHGKT---DCPGHADVPLNKCDM                                                                 vary level Sec4-1lel33p expressed, mutant gene <br />               -GAGESGKi B <br />                                                                                                           cloned various plasmids  Figure 1 Materials <br />  C                             DVGGORE <br />                                  S LtCKan t <br />                                                                                                           methods). efficiency plasmid pNB256 <br />                                                                                                            synthesize mutant protein low level) <br />                Ph_phry      BirNn              Guw        Ring Contwt Sho <br />                                                                                                           transformed wild-type cells equivalent  B. <br />                                                                                                           plasmid pNB227 (containing normal gene). <br />                                         L79       133          D147                sop                     plasmid pNB260, synthesize wild- <br />  SEC4      12-GDSGVGKSC-DTAGOER-LVGNKSDM-G-ESSAKNDKND <br />                                                                                    II <br />                                                                                                           type levels Sec4-Ile133p used, transformation <br />   Allele         Mutation           GTP-binding         Memrane        Phenotype      Cnplnemnetatio   efficiency reduced 10-fold compared transformation <br />                                                                                                                                  - <br />  <br />  <br />  <br />                                                         Anmacent       Presence                                                                        Wild-type SEC4 <br />                                                                                          sec4-8        control plasmid, pNB139. transformants  SEC4 <br />                                                                                                           obtained pNB225, synthesize high levels <br />                  Wild4ype <br />  sec4-8          GseDI47                                  +            Recessive <br />                                                                                                           mutant protein, analogous wild-type <br />                                                                        ts Lethal                          plasmid, pNB170, does yield colonies.  pNB225 <br />  sec4-32         CC=sA214                                 -            Recessive                          digested restriction enzymes create 70 bp <br />  sec4-20, 21.22 Ne1t33                                                 Dose Dependent                     gap Ilel33 mutation, transformation does occur <br />                                                                        Dminan Lethal <br />  sec4-21,31      Nes1I33+ <br />                                                                                                           gap repaired using endogenous wild-type <br />                                                                        Recessive <br />                   CC.oA2&apos;4                                                                                gene template (Orr-Weaver et al., 1981).   sec441          QeL79                                                 Recessive           +              inability obtain transformants pNB225 construc- <br />                                                                                                           tion sequence located deleted 70 bp Fig. 3.   Comparison regions involved GTP binding.                                            plasmid. change amino acid sequence portions Sec4p make                                            wild-type sequence region encodes Ile133 <br /> putative GTP binding site compared GTP binding regions known <span id='am-56' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-57' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="Guanine" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>guanine</span> nucleotide binding proteins. Based crystal                                     mutation. <br /> structure mammalian H-ras protein  Vos et al., 1988)                                           order study phenotype induced mutant conserved domains amino terminal end interact                                         protein constructed strain  addition wild- <br /> phosphoryl group. conserved domains carboxy end                                       type SEC4 gene present chromosomal locus, protein form pocket interaction guanine ring. <br /> Positions single amino acid substitutions alter GTP binding                                     SEC4Ile133 (pNB276) integrated URA3 locus hydrolysis activity H-ras p21 result oncogenic                                               (NY640). plasmid synthesize mutant protein <br /> transformation mammalian cells indicated * (G 12, Q 61,                                         levels approximately equivalent endogenous <br /> N 116). Sequences obtained  SEC4 (Salminen Novick,                                               Sec4p expression levels. mentioned  transfor- <br />  1987); YPTI (Gallwitz et al., 1983); H-ras (Capon et al., 1983); EF-                                     mation frequency wild-type cells mutant plasmid <br /> Tu (Arai et al., 1980); Gsay (Robishaw et al., 1986). (B) Summary behavior SEC4 alleles. regions Sec4p make                                       10-fold lower equivalent wild-type plasmid <br />                                                                                                                - <br />  <br />  <br />  <br />  <br /> GTP binding site shown, sites sec4-8                                            (pNB141). addition, growth rate cells expressing <br /> sec4-CCA mutations. GTP binding assayed nitrocellulose                                         Sec4-Ilel33p reduced. doubling time wild-type filter binding assay solution. Membrane attachment                                           - <br />                                                                                                              2 h doubling time NY640, cells expressing <br /> determined centrifugation 100 000 g. phenotypes listed                                          Sec4-11el33p addition wild-type Sec4p, 4 h <br /> reflect behavior various alleles SEC&apos; background. <br /> &apos;Dose-dependent dominant lethal&apos; reflects fact low levels                                     (data shown). protein tolerated, normal levels cause severe growth                                       examined efficiency secretion cells secretion defect wild-type cells high levels lethal SEC+                                  assaying release secreted enzyme invertase background. Complementation sec4-8 tests                                            cell surface. Approximately 40% invertase secreted <br /> encoded protein functional. <br />                                                                                                           NY640, cells expressing mutant protein, com- <br /> Sec4-8 mobility slower                                             pared wild-type cells (data shown). NY640 Sec4p Sec4-CCAp. shown Figure 2A, contrast                                                 analogous strain bearing extra copy SEC4 wild-type protein primarily high-speed                                             examined electron microscopy. dramatic increase pellet (P2), Sec4-CCA protein soluble                                            number secretory vesicles seen NY640 (Figure <br /> fraction (S2), suggests carboxy-terminal                                               4), despite presence wild-type Sec4p cells. <br /> cysteines necessary membrane attachment. Sec4-                                                     SEC4-Ie133 induces dominant secretory defect. CCAp does retain ability bind GTP (data shown).                                                vesicles strain similar size appearance                                                                                                           vesicles present late secretory mutants SEC441e 133 dominant lethal mutation                                                                 accumulate post-Golgi vesicles incubated crystal structures EF-Tu mammalian H-ras                                                restrictive temperature (Novick et al., 1980). <br /> protein allowed conclusive identification                                                    confirm phenotype conferred presence regions proteins interact bound guanine                                            Sec4-1le133p, gene cloned inducible <br /> nucleotide (Jurnak, 1985; LaCour et al., 1985; Vos et                                                  GAL] promoter integrated URA3 locus al., 1988). distinct domains higly conserved                                               SEC+GAL+ cells (NY519). control strain, NY496, large variety GTP-binding proteins (Figure 3A,                                                 wild-type SEC4 gene cloned GAL] Dever et al., 1987) form pocket nucleotide                                                 integrated URA3. 0, 6 12 h induction rests. Particular mutations domains H-ras result                                              galactose, cells harvested preparation lysates alleles lead oncogenic transformation                                                    measure Sec4p expression examination electron <br />  <br />                                                                                                                                                                   1687 <br />  N.C.Walworth et al. <br />  <br />  <br />  <br />  <br />     ves <br />  <br />  <br />                                                                                             , <br />                                                                                             ...      --    .- <br />                                                                                                                  0. <br />  <br />  <br />  <br />  <br />                                                                          Fig. 5. GTP binding ability mutant Sec4 proteins. Gal+ strains                                                                          Sec4 genes control inducible GALl promoter                                                                          induced galactose 12 h. Aliquots cells harvested 0, <br />                                                                          6 12 h induction, lysed glass beads boiled sample <br />                                                                          buffer. Samples separated SDS-polyacrylamide (15%) gel <br />                                                                          transferred nitrocellulose. filters shown panel <br />                                                                          incubated anti-Sec4p antibody followed [1251]protein                                                                          exposed X-ray film. panel, filters                                                                          incubated [cs-32P]GTP exposed X-ray film. Strains                                                                          follows (transformed strains plasmid integrated                                                                          URA3 locus): NY451 untransformed Gal + strain. NY496                                                                          NY451 SEC4 control GAL] promoter (Sec4p). <br />                                                                          NY519 NY451 SEC4-lle133 control GAL] <br />                                                                          (Sec4-23p). NY643 NY451 sec4-Leu79 control GAL] <br />                                                                          (Sec4-43p). NY456 sec4-8, Gal&apos; strain. NY644 NY456 Fig. 4. Cells expressing Sec4-Ilel33p contain large number          sec4-Leu79 control GAL]. <br /> secretory vesicles despite presence wild-type Sec4p. Cells harvested growth exponential phase fixed electron      Cells containing times wild-type protein microscopy.   NY640 wild-type SEC4 gene                 time accumulate secretory vesicles (Figure 6B). chromosomal locus SEC4-41el33 gene integrated URA3        12 h growth galactose, overexpression mutant <br /> locus. integrated plasmid, pNB276, synthesize normal          protein causes accumulation large number levels mutant protein. Bar = 0.5 ttm. (B) Wild-type strain <br /> containing extra copy wild-type SEC4 gene URA3          secretory vesicles, overexpression wild-type Sec4p <br /> locus shown magnification cell  . Typical     results slight accumulation membranes including wild-type cells, secretory vesicles seen section.         secretory vesicles  shown). growth rate                                                                          NY519 begins drop 4 h inducing expression <br /> microscopy. Western blot shown Figure 5 indicates                 mutant protein (Figure 6C), overexpression level Sec4p NY496 increases induction                wild-type protein NY496 12 h galactose, compared NY451, parental strain                effect doubling time.  production Sec4-11el33p does contain plasmid. Similarly, NY519 total              results secretory defect correlates decreased <br /> Sec4p overexpressed extent                growth rate, despite presence wild-type protein NY496. greater instability                cells. <br /> mutant protein. Sec4-Ile133p slightly faster mobility wild-type protein accompanying GTP                      Sec4-lle 133p dominant loss function mutant <br /> binding blot Figure 5 indicates mutant protein               SEC4-41e133 gene introduced sec4-8 strain <br /> does bind significant amounts radiolabeled nucleotide             pNB256, plasmid produces low levels assay. observation confirmed                    protein, transformed cells grow 25&#194;&#176;C able <br /> measuring GTP-&apos;y-S binding activity solution lysates               grow 37&#194;&#176;C. control shown sec4-8 cells protein overexpressed (Table              cells transformed pNB227 expressing wild-type . Sec4-Ilel33p 10 000 g                   allele able grow 37&#194;&#176;C.  Sec4-11el33p does <br /> 100 000 g pellet fractions following differential centrifuga-            appear wild-type function. Genetic analysis tion lysed spheroplasts indicating protein does              interaction SEC4 subset late acting <br /> attach membranes (data shown).                                    secretory mutants allows distinction    section electron microscopy, dramatic accumula-             gain loss Sec4p function. gain Sec4p function <br /> tion secretory vesicles seen NY519 early              achieved duplicating wild-type SEC4 gene, 6 h induction twice mutant              results suppression temperature-sensitive growth <br /> protein wild-type protein present cell (Figure 6A).            defect sec2-41, sec8-9 seciS-1 strains. loss Sec4p <br /> 1688 <br />                                                                                                           Regulation vesicular traffic Sec4p <br />  <br />  <br /> Table  GTP--y-S binding Sec4 proteins overexpressed sec4-8 background <br />  Induced protein (strain)               Specific                        Relative               Binding normalized               % wild-type <br />                                         GTP-y-S bindinga                Sec4 proteinb                    Sec4p level                   Sec4p <br />                                         (pmol/mg x 10)                                                   (pmol/mg x 10)                   binding <br />  Membrane fractionc <br />    Sec4p (NY500)                         14                             1                                14                               100 <br />    Sec4-Ile133p (NY520)                   0.5                           0.72                              0.7                               5 <br />    Sec4-Leu79p (NY644)                    8.0                           1.1                               7.3                              52 <br />  Soluble fractiond <br />    Sec4p (NY500)                         14                             1                                14                               100 <br />    Sec4-Ile133p (NY520)e                      -                         0.25 <br />    Sec4-Leu79p (NY644)                   11                             1.2                               9.2                              66 <br />  <br /> aCells grown presence galactose 24 h induce expression indicated proteins. Spheroplasts lysed osmotically centrifuged 100 000 g 1 h. assay measures binding [35S]GTP-y-S solution using rapid filtration technique. Specific binding calculated difference binding presence 1 mM AppNHp binding presence 1 mM GppNHp. Binding specific induced protein calculated subtracting detected equivalent fraction strain NY456, GAL+, sec4-8 strain. Values <br /> represent average binding experiments duplicate samples assayed. <br /> bThe levels Sec4 protein fraction determined quantitative Western blot analysis. Counts normalized number counts <br /> detected equivalent fraction NY500, strain overproducing Sec4p. <br /> cPellet fraction 100 000 g centrifugation. Specific binding values represent total binding minus detected equivalent fraction NY456: 5.5 pmol/mg x 10. <br /> dSupematant fraction 100 000 g centrifugation. Specific binding values represent total binding minus detected equivalent <br /> fraction NY456: 2.2 pmol/mg x 10. <br /> eThe Sec4-Ilel33p present fraction low assess binding. <br /> function tolerated particular mutants                    C-terminal portion SEC4-41el33 gene <br /> strains bearing sec4-8 mutation sec2-41,                   replaced portion sec4-CCA gene <br /> sec8-9 secl5-J constructed (Salminen                          bearing cysteine deletion. gene introduced <br /> Novick, 1987).                                                                 wild-type SEC&apos; background obvious effect    Analysis behavior SEC4-lle133 allele                       growth observed gene expressed crosses sec strains indicates behaves                  normal level (pNB286) high level (pNB285). Western <br /> loss function allele. behavior dominant,                 blot analysis cell fractionation experiments indicates case wild-type SEC4 gene present. Strains                          protein mol. wt Sec4-Ilel33p containing SEC4-Ile133 (marked Ura+) strains                            soluble (Figure 2B).  removal cysteines, <br /> bearing sec mutations (marked temperature                             makes Sec4-1lel33p soluble wild-type cells, relieves <br /> sensitivity) crossed resulting diploids                           dominant lethality mutant protein. <br /> sporulated. SEC441e133 mutant gene synthesized wild-type levels lethal combined subset                  Sec4-Leu79p binds GTP efficiently, sec mutants recessive, temperature-                          functional <br /> sensitive sec4-8 mutant lethal (Salminen Novick, 1987)                  mutation domain GTP binding site responsible functional copy SEC4 present (Tables II                      interacting phosphoryl group GTP causes ras Ill). crosses SEC4-Ile133  example,                     transforming activity  Figure 3A). mutation, <br /> seciS-l, tetrads inviable spores.                          changes glutamine position 61 leucine, causes <br /> Phenotypic analysis remaining viable spores indicated                   protein hydrolyze GTP 10-fold slower rate. inviable spore contained seciS-]                  glutamine changed amino acids Ura+ marked SEC4-11e33 allele.                                leucine, hydrolysis rate decreased protein <br /> combination seclS-] SEC4-Ilel33 lethal event.                      various degrees transforming ability depending results obtained sec2-41 sec8-9.                    specific amino acid substituted (Der et al., 1986). phenotype specific, crosses vesicle accumulating                    changed analogous glutamine position 79 Sec4p mutants secl-Ji sec6-4, crosses Golgi                  leucine. <br /> accumulating mutant sec7-1 endoplasmic reticulum                          Sec4-Leu79p able bind GTP filter assay <br /> accumulating mutant secl8-1, yielded viable temperature-                   (Figure 5) quantitative solution assay sensitive, ura+ spores. SEC41el33 present low                     mutant protein binds nucleotide 50-60% wild-type <br /> expression plasmid, viable ura+, temperature-sensitive                    levels (Table . assays rule spores obtained indicating low levels                       possibility rate rate GTP binding mutant protein tolerated sec mutants                  mutant protein different rates wild-type functional copy SEC4 present (tetrad data                     protein. Introduction protein wild-type cells shown, summarized Table III).                                           obvious effect cell growth. introduced                                                                                temperature-sensitive sec4-8 cells expressed normal <br /> Analysis Sec4-lle 133, CCA                                                  levels (pNB287), protein does rescue temperature- deletion cysteine residues causes Sec4p                        sensitive growth defect cells.  soluble non-functional, tested                      Sec4-Leu79p binds GTP altered characteristics removal dominant Sec4-1lel33p prevent                     compared wild-type protein, functional.  protein detrimental. gene constructed                    protein expressed higher normal levels                                                                                                                                                 1689 <br />  N.C.Walworth et al. <br />  <br />                                                                            Discussion <br />                                                                            behaviors various Sec4 mutant proteins                                                                            summarized Figure 3B. proteins examined <br />                                                                            capacity bind GTP attach membranes. <br />                                                                            Complementation temperature-sensitive growth defect <br />                                                                            sec4-8 used determine                                                                            functional. phenotypes induced mutant <br />                                                                            proteins wild-type cells cells containing                                                                            secretory defects documented. behavior                                                                            mutants consistent Sec4p playing cyclical role <br />                                                                            mediating transport secretory vesicles plasma <br />                                                                            membrane yeast. <br />                                                                            Relationship Sec4p localization function <br />                                                                            shown previously Sec4p cell <br />                                                                            stably associated plasma membrane secretory <br />                                                                            vesicles despite hydrophilic nature protein <br />                                                                            sequence. soluble pool 10-15% total Sec4p                                                                            maintained evidence indicates protein                                                                            recycle plasma membrane secretory vesicles                                                                            probably soluble intermediate (Goud et al., 1988). <br />                                                                            structurally related ras family GTP-binding proteins, <br />                                                                            including yeast Yptlp, attach cytoplasmic surfaces <br />                                                                            cellular membranes lipid moiety linked                                                                            C-terminal cysteine (Chen et al., 1985; Buss Sefton, <br />                                                                            1986; Fujiyama Tamanoi, 1986; Molenaar et al., 1988). <br />                                                                            Yptlp shown palmitoylated deletion                                                                            cysteines results soluble, unmodified protein <br />                                                                            (Molenaar et al., 1988). Like Yptlp, Sec4p terminates                                                                            cysteines (Salminen Novick, 1987). Deletion                                                                            amino acid residues results majority                                                                            protein remaining soluble. protein functional                                                                            retains ability bind GTP. suggests                                                                            cysteines necessary mediating stabilizing                                                                            attachment Sec4p membranes association <br />                                                                            required normal function. modification                                                                            palmitoylation detected. <br />  <br />                                                                            SEC4-lle 133 dominant secretory mutant <br />                                                                            SEC4-4e133     constructed based behavior                                                                            transforming mutant H-ras dominant lethal mutant <br />                                                                            YPTI (Schmitt et al., 1986; Walter et al., 1986). <br />                                                                            Mutations p21 H-ras position 116 119                                                                            domain GTP-binding site decrease protein&apos;s affinity <br />                                                                            GTP GDP. Despite lowered affinity                                                                            nucleotide, particular substitutions 116 119 result                                                                            transformation competent ras proteins, assumed <br /> Fig. 6. Induced expression Sec4-Ilel33p causes accumulation                                                                            constitutively active (Sigal et al., 1986; Walter et al., <br /> secretory vesicles decrease growth rate. growth rate       1986). mutation domain yeast YPTI <br /> cells expressing wild-type Sec4p Sec4-Ile133p control          gene position 121 changes asparagine isoleucine GAL] followed induction galactose cells            prevents protein binding GTP. Schmitt et al. (1986) <br /> harvested electron microscopy.   6 h induction         proposed dominant lethal phenotype induced <br /> galactose, cells expressing Sec4-Ilel33p (NY519) accumulate large <br /> number secretory vesicles. Bar = 0.5 ,tm. (B) time          mutant protein locked active <br /> point, cells expressing Sec4p (NY496) display normal morphology.         conformation. SEC4-lle133 mutation constructed <br /> (C) 12 h induction galactose growth rate cells        mimic situation. expected, Sec4-Ilel33p expressing wild-type Sec4p normal 6 h growth rate        defective GTP binding. protein expressed cells expressing mutant Sec4-Ilel33p slowed. Open squares    = <br />  <br /> NY451. Closed diamonds = NY496. Open triangles       =  NY519.             normal levels cells expressing wild-type <br />                                                                            Sec4p, cells grow slowly. addition, cells <br />                                                                            secrete lower levels invertase accumulate excess <br /> sec4-8    pNB293)     cells grow          slower rate   secretory vesicles cytoplasm. postulate 37&#194;&#176;C cells expressing level wild-type                  reversible interaction Sec4p effector <br /> Sec4p (data shown). phenotype reflect                     molecule. interaction irreversible case <br /> altered binding activity protein.                                  mutant protein   prevents wild-type <br /> 1690 <br />                                                                                                             Regulation vesicular traffic Sec4p <br />  <br />  <br /> Table 11. Tetrad analysis URA3:: SEC4-41el33 crossed ts- sec mutants <br />                                               Categories tetrads: distribution crosses <br />                                               2 ts+ura&apos;               ts+ura&apos;                                      1 ts+ura+ <br />                                               2 ts-ura-               1 ts-ura-                                      ts-ura- <br />                                                                       1 tstura-              2 ts+ura-               1 ts+ura-                2 ts+ura- <br />                                                                       1 ts-ura&apos;              2 ts-ura&apos; <br />                                                                                                                      inviablea              2 inviablea <br />  URA3:: SEC4-11e133   x se(4-8                3                                                                      1                        8 <br />  NY64()                 NY405 <br />  URA3:: SEC4-11e133   x se(l5-1                                                                                      9                        2 <br />  NY640                   NY64b <br />  URA3:: SEC4-11e133   x sec2-41               3                                                                      8                        1 <br />  NY640                  NY130 <br />  URA3:: SEC4-11e133   x sec8-9                 1                                                                     8                        2 <br />  NY640                  NY410&apos; <br />  URA3:: SEC4-4le133   x se(6-4                2                      8                      1 <br />  NY640                   NY17d <br />  URA3:: SEC4-11e133   x seel-II                1                     6                      3 <br />  NY640                  NY24&apos; <br />  URA3:: SEC4-41el33   x sec7-1                                       8 <br />  NY640                  NY 176&apos; <br />  URA3::SEC4-41el33    x seel8-1                1                     9                      1 <br />  NY640                  NY43I <br />  <br /> aThe absence ts ura+ spores indicates combination ura+ marked SEC4-11eI33 SEC4-I1e133,CCA allele indicated ts- seC <br /> allele lethal event. <br /> Additional tetrads <br /> bi tetrad, viable spore: ts-ura-. <br /> cl tetrad; 2 viable spores: ts-ura-; ts ura-. <br /> dl tetrad; 4 viable spores: ts-ura&apos;: 2 ts-ura-; ts+ura-. <br /> &apos;2 tetrads, 4 viable spores: ts+ura+; 2 ts-ura-, ts+ura-. <br />  11 tetrad, 4 viable spores: ts+ura+; ts+ura-; 2 tsura&apos;, 1 tetrad; 4 viable spores: 2 ts+ura+; ts--ura-; ts-ura&apos;, 1 tetrad; 4 viable spores: ts+ura+; <br /> ts ura7 ts ura+; ts+ura: 1 tetrad. 3 viable spores: ts+ura+; ts+ura-; ts-ura&apos;. <br />  tetrad; 3 viable spores: ts ura ; ts-ura-; ts-ura&apos;. <br />  <br /> protein function responsible dominant nature mutation.                                                              Table III. Summary genetic interactions: double mutant viability                                                                               25 &#194;&#176;C <br />    Evidence SEC4-41el33 dominant loss function <br /> mutant comes genetic experiments. Previous studies                        ts- strain       Site block    NY405             NY640          NY617 <br /> (Salminen Novick, 1987) shown gain                                           37&#194;&#176;C          sec4-8            sec4-2IP       sec4-20P <br />                                                                                                                                    SEC4           SEC4 <br /> Sec4p function case SEC4 duplication suppress temperature-sensitive growth defects set                     sec4-8           vesicle                            -              + vesicle-accumulating sec mutants including seclS-]                      sec2-41          vesicle          -                 -              + <br /> sec2-41. loss Sec4p function, exemplifed                        sec 8-9          vesicle          -                 -              + <br /> presence sec4-8 sole copy SEC4, lethal                      secl5-1          vesicle          -                 -              + <br /> strains bearing mutations. SEC4-41el33 gene,                   secl-1l          vesicle          +                 + introduced strains level permits                     sec6-4           vesicle          +                 + <br />  <br /> viability wild-type background, behaves loss                      sec7-1           Golgi            +                 + <br />                                                                                sec l8-1         ER               +                 + <br /> function allele, e. combination SEC4-41el33 seciS-1 sec2-41 lethal. Importantly, inviability                 asec4-21: SEC4-lle133 normal level. <br /> seen specifically strains known interact                bsec 4-20: SEC4-Ile133 low level. genetic level SEC4. Introduction SEC4-41el33 sec6-4, secl-11, sec7-J sec]8-1 lethal               conformation Sec4p recognizes attachment site newly mutations suppressed duplication                   formed secretory vesicle. complex recognized SEC4 inviable combined sec4-8 (Salminen                         hypothetical effector cytoplasmic surface plasma Novick, 1987).                                                            membrane triggering membrane fusion exocytosis.                                                                               analogy, release Sec4p effector coupled Sec4p functions cycle                                            dependent hydrolysis bound GTP leading models mechanism action GTP-binding                         conformational change. <br /> proteins discussed  Introduction). model                      failure bind nucleotide efficiently leave Sec4p <br /> shown Figure 7 based loosely mechanism                        inactive active conformation. EF-Tu functions deliver aminoacyl-tRNA                     phenotype cells expressing Sec4-lle l 33p consistent ribosome (Kaziro, 1978; Bourne, 1988). steady state,                       hypothesis trapped active conformation. <br /> Sec4p cell soluble form, bound                 competent attach vesicles enter secretory vesicles bound plasma membrane.                       cycle, relax inactive <br /> Sec4p binds GTP postulate GTP-bound                        conformation blocks cycle. Vesicles formed                                                                                                                                                       1691 <br />   N.C.Walworth et al. <br />  <br />  <br />  <br />  <br />              bF      ,       l <br />                                          .~~~~~        / <br />                                                         ,~ ~  <br />                                                         <br />                                                                  <br />                                                                r:. <br />                                                                         Table IV. Strains used <br />                                                                          Strain <br />                                                                          NY13 <br />                                                                          NY15 <br />                                                                          NY17 <br />                                                                          NY24 <br />                                                                          NY64 <br />                                                                          NY 130 <br />                                                                          NY176 <br />                                                                          NY405 <br />                                                                          NY410 <br />                                                                          NY451 <br />                                                                                       Genotype <br />                                                                                       MATa, ura3-52 <br />                                                                                       MATa, ura3-52, his4-619 <br />                                                                                       MATa, ura3-52, sec6-4 <br />                                                                                       MATa, ura3-52, secl-Ji <br />                                                                                       MATa, ura3-52, secl5-1 <br />                                                                                       MATa, ura3-52, sec2-41 <br />                                                                                       MA Ta, ura3-52, sec7-1 <br />                                                                                       MATa, ura3-52, sec4-8 <br />                                                                                       MATa, ura3-52, sec8-9 <br />                                                                                       MATa, ura3-52, Gal&apos; <br />                                                                          NY456        MATa, ura3-52, Gal&apos;, sec4-8 <br />                                                                          NY496        MATa, ura3-52:: (URA3, GALJ-SEC4), Gal+ <br />                                                                          NY500        MATa, ura3-52:: (URA3, GAL1-SEC4), sec4-8, Gal+ <br />                                                                          NY519        MATa, ura3-52:: (URA3, GALI-SEC4-23), Gal+ <br />                                                                          NY520        MATa, ura3-52:: (URA3, GALJ-SEC4-23), sec4-8, Gal+ <br />                                                                          NY617        MATa, ura3-52:: (URA3, sec4-20), his4-619 <br />                                                                          NY637        MATTa, ura3-52:: (URA3, sec4-21,31), his4-619 <br />                                                                          NY639       MAToe, ura3-52:: (URA3, SEC4), his4-619 <br />                                                                          NY640       MAToe, ura 3-52::(URA3, SEC4-21), his4-619 <br />                                                                          NY643       MATa, ura3-52:: (URA3, GALI-sec4-43), Gal&apos; <br />                                                                          NY644       MATa, ura3-52:: (URA3, GALJ-sec4-43), Gal+ <br />                                                                          NY678       MATa, ura3-52, pNB254 (URA3, sec4-32), sec4-8 <br />                                                                          NY682       MATa, ura3-52, pNBJ70 (URA3, SEC4), sec4-8 <br />                                                                          sec4 <br /> Fig. 7. Model Sec4p function. GDP bound Sec4p exchanged GTP. GTP-bound conformation Sec4p recognizes        alleles attachment site newly formed secretory vesicle. complex     sec4-8 recognized effector cytoplasmic surface plasma <br />                                                                                      Sec4-Asp147 <br /> membrane-triggering membrane fusion exocytosis. Release                                                                          sec4-20     Sec4-IIeJ33 (low) <br /> Sec4p effector coupled hydrolysis bound GTP. <br />                                                                          sec4-21     Sec4-IIel33p (normal) <br />                                                                         sec4-21,31 Sec4-Ile133p,CCA (normal) <br />                                                                         sec4-23    Gal/Sec4-Ilel33   effector necessary vesicle delivery place      sec4-32    Sec4-CCA (high) <br />  unavailable bound activated Sec4p              sec4-43    Gal/Sec4-Leu79 <br />  previous round. dominant mutant, Sec4-Ilel33p <br />  prevents wild-type protein functioning manner  suggests Sec4p interacts directly specific              shown interact SEC4 genetic level.  component(s) cycle. Lowering level mutant                dominant SEC4-Ile133 allele provides tool  protein allows wild-type protein compete function               probe interacting proteins genetic <br />  effectively. higher level mutant protein does             biochemical level. Furthermore, studies  permit wild-type protein function  Significantly,         biochemical properties Sec4p identification  normal levels synthesis secretory defect             factors influence properties promise  induced presence Sec4-Ilel33p seen.                       revealing. <br />     yeast Ras/adenylate cyclase number  components regulatory pathway identified                   Materials methods <br />  suppressor analysis (Toda et al., 1985; Cannon et <br /> al., 1986). attempted identify suppressors loss               Yeast genetic techniques <br />                                                                         Yeast strains used study listed Table IV. Cells grown Sec4p function isolating revertants sec4-8 strain.           rich medium (YPD) containing 1 % Bacto-yeast extract, 2 % Bacto-Peptone  intragenic suppressors obtained (data                (Difco Laboratories, , Detroit, MI) 2 % glucose carbon source shown). failure obtain extragenic suppressors            indicated. selective conditions required cells reflect fundamental difference mechanism               grown minimal medium containing 0.7% yeast nitrogen base Ras2p regulates cell cycle mechanism               amino acids (Difco) 2% glucose, supplemented auxotrophic Sec4p regulates vesicular traffic.                 requirements, described Sherman et al. (1974), necessary. <br />                                                                            Yeast transformation method alkali cation treatment <br /> adenylate cyclase involves amplification             (Ito et al., 1983). Transformants selected minimal medium 25&#194;&#176;C. second messenger molecule, constitutive activation                 Crosses, sporulation diploids dissection tetrads downstream components pathway suppresses loss                described Sherman et al. (1974). function Ras protein, upstream regulatory                 Nucleic acid techniques <br /> molecule. Loss Sec4p function suppressible                Escherichia coli strain DH 1 used cloning experiments. Plasmid similar manner operate cyclical fashion.           preparations essentially described (Silhavy et al., <br />    Future studies role Sec4p directed              1984). Centromere-containing plasmids pNB 139 pNB170 encoding identification components interact               SEC4 genes described Salminen Novick (1987) plasmid <br />                                                                         pNB227 constructed sub-cloning BamHI -EcoRI fragment Sec4p function cycle. Candidates proteins          pNB170 BanHI-SphI site YCp5O, reverses orientation involved products genes             SEC4 gene respect URA3 gene plasmid. Mutant <br />  <br /> 1692 <br />                                                                                                             Regulation vesicular traffic Sec4p <br />  <br /> SEC4 genes cloned plasmids integrating versions     Barbacid,M. (1987) Annu. Rev. Biochem., 56, 779-827. <br /> plasmids (YIpS derivatives) M 13 vectors mutants          Boume,H.R. (1988) Cell, 53, 669-671. constructed  . parent integrating plasmid containing         Buss,J. Sefton,B. (1986) Mol. Cell. Bio., 6, 116-122. GALl -SEC4 construct (pNB219) described Goud et al. (1988)            Cannon,J.F., Gibbs,J.B. Tatchell,K. (1986) Genetics, 113, 247-264. mutant derivatives constructed direct mutagenesis portion      Capon,D.J., Chen,E.Y., Levinson D., Seeburg,P.H. Goeddel,D.V. plasmid sub-cloning mutagenized M13 pNB219.               (1983) Nature, 302, 33-37. <br />    Mutagenesis carried using Amersham oligonucleotide directed      Chen , Ulsh,L.S., DuBois,G. Shih,T.Y. (1985) J. Virol., 56, vitro mutagenesis kit according manufacturer&apos;s instructions              607-612. <br /> (Amersham, Arlington Heights, . Oligonucleotides synthesized         Der,C., Finkel,T. Cooper,G.M. (1986) Cell, 44, 167-176. Yale University DNA Synthesizing Service. sequences mutant       Deschenes,R  Broach,J.R. (1987) Mol. Cell. Bio., 7, 2344-2351. <br /> genes confirmed dideoxy chain termination method (Sanger            Dever,T.E., Glynias,M.J. Merrick,W.C. (1987) Proc. Natl. Acad. Sci. <br /> et al., 1977) presence [cs-35S]<span id='am-21' about='obo:IMR_0200129' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-22' property="oboInOwl:id" content="IMR:0200129" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasDbXref" content="KEGG:C00131" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="dATP" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>dATP</span> (650 Ci/mmol; Amersham)              USA, 84, 1814-1818. <br /> (Williams et al., 1986). construct 1le33 mutation EcoRI-HindIlI      Vos M., Tong,L., Milburn,M.V., Matias,P.M., Jancarik,J., <br /> fragment pNB219 subcloned mpl8, M13 derivative                 Noguchi,S., Nishimura,S., Miura,K., Ohtsuka,E. Kim,S.-H. (1988) <br /> mutagenized using 25 base oligonucleotide encoding Ile instead Asn:           Science, 239, 888-893. <br /> 5&apos;CATATCGCTCTTAATACCAACCAAC3&apos;. construct CCA                             Fujiyama  Tamanoi,F. (1986) Proc. Natl. Acad. Sci. USA, 83, <br /> mutant Hindmll-EcoRI fragment pNB170 cloned M13               1266-1270. <br /> derivative mpl9 mutagenized using 30 base oligonucleotide        Gallwitz,D., Donrath,C. Sander,C. (1983) Nature, 306, 704-709. codons cysteines C terminus deleted: 5&apos;AGTTCTAA-             Gilman  (1987) Annu. Rev. Biochem., 56, 615-649. <br /> ATCAAATATGAAGAAAAGAAGAT3&apos;. construct Leu 79 mutant                       Goud,B., Salminen , Walworth,N.C. Novick,P.J. (1988) Cell, 53, BamHI-HindIII fragment pNB139 EcoRl-HindIll                       753-768. <br /> fragment pNB190  YCpSO version pNB219) cloned                   Holm,C., Meeks-Wagner,D., Fangman,W. Botstein,D. (1986) Gene, <br /> independently mpl 8 mutagenized using 24-base oligonucleotide           42, 169-173. <br /> encoding Leu instead Gln: 5&apos;GGAAACGTTCCAAACCAGCGGTAT3&apos;.                      Ito,H., Fukuda,Y., Murata,K. Kimura  (1983) J. Bacteriol., 153, <br /> M13 plasmids propagated E.coli strain TG1  mutagenesis)              163-168. <br /> JM101  sequencing).                                                         Jurnak,F. (1985) Science, 230, 32-36. <br />                                                                                 Kaziro,Y. (1978) Biochim. Biophys. Acta, 505, 95-127. <br /> Expressing SEC4 GAL 1 promoter                                         LaCour,T.F.M., Nyborg,J., Thirup,S. Clark,B.F.C. (1985) EMBO <br /> Cells grown YP medium containing 2% lactate. Expression               J., 4, 2385-2388. GALl promoter induced using 0.5% galactose, 0. 1 % glucose,          Lapetina,E. Reep,B. (1987) Proc. Natl. Acad. Sci. USA, 84, <br /> included maintain moderate level expression (Adams, 1972).                  2261 -2265. <br />                                                                                 Molenaar,C., Pranger,R. Gallwitz,D. (1988) EMBO J., 7, 971-976. methods                                                                   Neer,E.J. Clapham,D.E. (1988) Nature, 33, 129-134. <br /> Electron microscopy carried described Walworth Novick         Northup,J.K., Smigel,M.D. Gilman G. (1982) J. Biol. Chem., 257, <br /> (1987). Electrophoresis immunoblotting described Goud et al.             11416-11423. <br /> (1988). Glass bead lysates prepared harvesting 5 x 107 cells,           Novick,P., Field,C. Schekman,R. (1980) Cell, 21, 205-215. <br /> washing 1 ml cold 10 mM Tris, pH 7.5, 10 mM NaN3, resuspending            Orr-Weaver,T.,Szostak,J. Rothstein,R. (1981) Proc. Natl. Acad. Sci. 75 Al buffer, adding glass beads reach meniscus.          USA, 78, 6354-6358. <br /> Lysis achieved mixing 3 min Vortex mixer (VWR                 Robishaw,J.D., Russell,D.W., Harris,B , Smigel,M.D. Gilman G. <br /> Scientific) 4&#194;&#176;C cold room followed immediately addition SDS             (1986) Proc. Natl. Acad. Sci. USA, 83, 1251-1255. <br /> sample buffer boiling. Osmotic lysis spheroplasts essentially   Salminen  Novick,P. (1987) Cell, 49, 527-538. Goud et al. (1988). Following homogenization, cell lysates spun      Sanger,F., Nicklen,S. Coulson R. (1977) Proc. Nat!. Acad. Sci. USA, 450 g, pellets washed pooled supernatants spun              74, 5463-5467. <br /> 100 000 g SW50. 1 rotor (Beckman Instruments) 33 000 r.p.m.         Schmitt,H., Wagner,P., Pfaff,E. Gallwitz,D. (1986) Cell, 47,401-412. <br /> 1 h generate membrane soluble fractions. GTP binding                  Segev,N., Mulholland,J. Botstein,D. (1988) Cell, 52, 915-924. <br /> nitrocellulose filters according Lapetina Reep (1987).          Sherman,F., Fink,G. Lawrence,? (1974) Methods Yeast Genetics. <br /> GTP-y-S binding solution measured rapid filtration technique         Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. <br /> utilizing HA MF-type membrane filters (Millipore, Bedford, MA)               Sigal,T., Gribbs,J., D&apos;Alonzo,J., Temeles,G., Wolanski,B., Socher,S. described Northup et al. (1982). soluble membrane fractions,           Scolnick,E. (1986) Proc. Natl. Acad. Sci. USA, 83, 952-956. <br /> 7.5-10 g protein assayed 25 i1 50 mM Hepes, pH 8.0,              Silhavy,T., Berman,M. Enquist,L. (1984) Experiments Gene <br /> 50 mM MgCl2, 200 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1%                     Fusions. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. <br /> Lubrol 2 ttM [355]GTP--y-S (Amersham, 5 x 105 c.p.m.) 30&#194;&#176;C           Toda,T., Uno,j., Ishikawa,T., Powers,S., Kataoka,T., Broek,D., <br /> 60 min. appropriate, <span id='am-31' about='obo:IMR_0200445' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-32' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasDbXref" content="KEGG:C00387" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:id" content="IMR:0200445" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="guanosine" datatype="xsd:string"></span>guanosine</span>-5&apos;-(3,-y-imino)<span id='am-36' about='obo:IMR_0200358' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-37' property="oboInOwl:id" content="IMR:0200358" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasDbXref" content="KEGG:C00536" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="Triphosphate" datatype="xsd:string"></span>triphosphate</span>                   Cameron,S., Broach,J., Matsumoto,K. Wigler,M. (1985) Cell, 40, <br /> [Gpp(NH)p] <span id='am-26' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span>adenine</span>-5&apos;-(f,,y-imino)triphosphate [App(NH)p] added             27-36. 1 mM (Boehringer Mannheim).                                                  Trahey,M. McCormick,F. (1987) Science, 238, 542-545. <br />                                                                                 Walter,M., Clark,S. Levinson  (1986) Science, 233, 649-652. <br />                                                                                 Walworth,N. Novick,P. (1987) J. Cell Biol., 105, 163-174. <br /> Acknowledgements                                                                Williams,S., Slatko,B., Moran,L. deSimone,S. (1986) BioTechniques, <br />                                                                                    4, 139-148. thank Drs P.DeCamilli, Mellman, H.Boume, S.Powers, Tamir             Willumsen,B., Christensen , Hubbert,N., Papageorge  Lowry,D. <br /> J.Northup helpful discussions. thank M.Talmor synthesis              (1984a) Nature, 310, 583-586. <br /> oligonucleotides, H.Stukenbroek R.Dowin assistance section      Willumsen,B.M., Norris,K., Papageorge G., Hubbert,N.L. electron microscopy Curley-Whitehouse assistance photography.         Lowry,D.L. (1984b) EMBO J., 3, 2581-2585. work supported grants GM35370 CA46218 National Institutes Health. N.C.W. supported training grant         Received 27th January, 1989; revised 20th March, 1989 National Institutes Health, B.G. supported grant Swebilius Foundation K.K. supported grant th <br /> </body></html>